Perlegen Sciences to Use EMR to Identify & Develop Genetic Markers to Personalize Medical Treatment

OPEN MINDS On-Line News Strategic Health Care News On March 18, 2008, Perlegen Sciences, Inc. announced that has partnered with an undisclosed electronic medical records (EMR) provider to identify and develop genetic markers to personalize medical treatments. These genetic markers would help to predict how an individual will respond to any given treatment. Perlegen and its partner will use data from the EMR, which contains clinical treatment and outcome data on nearly four million patients. Perlegen will work with each patient's individual health care provider to seek to obtain DNA from selected patients in a method that is . . .